What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

New Genetic Test Predicts How You'll Respond to Prescription Drugs

August 24, 2013, 9:00 AM

What's the Latest Development?

A genetic test to be marketed directly to consumers will test their genetic make up to determine how they will react to prescription drugs, and whether a nonstandard dose should be taken "because their body will break it down faster or slower than most people." The test, under development at the New Jersey-based startup Genome Liberty, would require patients to send a saliva sample to the company's laboratory. Genetic analysts would then scan the individual's genome for "DNA variations in 11 liver enzyme genes, which are a subset of the dozens of genes encoding enzymes for drug metabolism."

What's the Big Idea?

Expected to cost $99, the test aims to tell patients which drugs they should take in which doses, and which drugs they should avoid according to markers in their DNA. Cofounder Jeffrey Rosenfeld, a genome scientist at Rutgers University, said: "The idea is to give you a card to keep in your wallet, or an iPhone app, which says which medications you shouldn't take." An important test for the company, as well as new medical technologies aimed directly at patients, is whether doctors will accept the legitimacy of the tests' results. Besides not automatically trusting direct-to-consumer tests, doctors may not have guidelines for how to interpret their results. 

Photo credit: Shutterstock.com

Read it at MIT Technology Review


New Genetic Test Predicts H...

Newsletter: Share: